News Release

Persistence barcodes: Reducing bias in radiological analysis

“Persistence barcodes emerge as a promising tool in radiological analysis, offering a novel approach to reduce bias and uncover hidden patterns in medical imaging.”

Peer-Reviewed Publication

Impact Journals LLC

Persistence barcodes: A novel approach to reducing bias in radiological analysis

image: 

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

view more 

Credit: Impact Journals, LLC

“Persistence barcodes emerge as a promising tool in radiological analysis, offering a novel approach to reduce bias and uncover hidden patterns in medical imaging.”

BUFFALO, NY - November 20, 2024 – A new editorial was published in Oncotarget's Volume 15 on November 12, 2024, entitled, “Persistence barcodes: A novel approach to reducing bias in radiological analysis.”

This editorial, authored by Yashbir Singh, Colleen Farrelly, Quincy A. Hathaway and Gunnar Carlsson from the Department of Radiology, Mayo Clinic (Rochester, MN), introduces persistence barcodes as a groundbreaking tool in medical imaging, particularly radiology. 

Derived from topological data analysis (TDA), this method transforms complex medical images into clear, interpretable patterns. By highlighting features such as tissue densities, blood vessels, and tumors, persistence barcodes reduce diagnostic bias and uncover subtle details that traditional artificial intelligence (AI) systems might miss. This innovative approach holds great promise for enhancing diagnostic accuracy and improving patient care.

Unlike some AI tools, like Graph Neural Networks, which risk oversmoothing and blurring critical features, persistence barcodes preserve key structural details. This method visualizes how features in medical images emerge, persist, and fade across different scales, providing clearer insights into the data.

By detecting subtle changes in tissue density that could indicate early disease and filtering out irrelevant artifacts or noise from imaging errors, persistence barcodes enhance diagnostic accuracy and reliability.

Persistence barcodes enhance fairness and consistency by standardizing analyses across different machines and radiologists, ensuring reliable diagnoses regardless of the imaging system. Their robustness against equipment-related variations makes them a valuable tool for improving diagnostic accuracy in diverse clinical settings.

While promising, the integration of persistence barcodes into routine medical practice faces challenges, such as the computational demands of processing high-resolution images and the need for user-friendly visualization tools. 

As we continue to refine and validate this approach, persistence barcodes could play a crucial role in developing more accurate, consistent, and unbiased diagnostic tools. This, in turn, has the potential to improve patient outcomes and advance the field of radiology as a whole.” 

In conclusion, with continued development and refinement, persistence barcodes have the potential to revolutionize medical imaging by facilitating earlier and more accurate disease detection, minimizing diagnostic errors, and significantly improving patient outcomes.

Continue reading: DOI: https://doi.org/10.18632/oncotarget.28667

Correspondence to: Yashbir Singh - singh.yashbir@mayo.edu

Keywords: cancer, persistence barcodes, radiology, image features

Click here to sign up for free Altmetric alerts about this article.

About Oncotarget:  

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

X
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Spotify, and available wherever you listen to podcasts

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact media@impactjournals.com.  

 Oncotarget Journal Office
6666 East Quaker St., Suite 1
Orchard Park, NY 14127


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.